COGNITION THERAPEUTICS INC Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cognition Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Cognition Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$9.94M, a 47.2% decline year-over-year.
  • Cognition Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$34.3M, a 50.1% decline year-over-year.
  • Cognition Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$25.8M, a 20.5% decline from 2022.
  • Cognition Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$21.4M, a 82.6% decline from 2021.
  • Cognition Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$11.7M, a 49.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$25.8M -$4.39M -20.5% Jan 1, 2023 Dec 31, 2023 10-Q 2024-11-13
2022 -$21.4M -$9.68M -82.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$11.7M -$3.88M -49.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$7.84M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.